Vassili Soumelis

Vassili Soumelis is currently the Chief Medical Officer at Owkin, where Vassili is responsible for medical and global strategy. Vassili also serves on the company's executive committee and is involved in driving biopharma transition activities. With a background in immunology and inflammatory networks, Vassili has held various roles in research, academia, and clinical practice throughout their career. Vassili has expertise in integrative biology, cellular linguistics, and the development of new strategies for immunotherapy of cancer.